Jagsonpal Pharmaceuticals Ltd vs Vasundhara Rasayans Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 206.8 as of 05 May 15:30 . The P/E Ratio of Jagsonpal Pharmaceuticals Ltd changed from 12.2 on March 2021 to 25.9 on March 2025 . This represents a CAGR of 16.25% over 5 yearsThe P/E Ratio of Vasundhara Rasayans Ltd changed from 7.6 on March 2021 to 17.3 on March 2025 . This represents a CAGR of 17.88% over 5 years The Market Cap of Jagsonpal Pharmaceuticals Ltd changed from ₹ 208.41 crore on March 2021 to ₹ 1433 crore on March 2025 . This represents a CAGR of 47.06% over 5 yearsThe Market Cap of Vasundhara Rasayans Ltd changed from ₹ 22.22 crore on March 2021 to ₹ 73.37 crore on March 2025 . This represents a CAGR of 26.99% over 5 years The revenue of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 67.37 crore as compare to the Dec '25 revenue of ₹ 75.92 crore. This represent the decline of -11.26% The revenue of Vasundhara Rasayans Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 8.12 crore. This represent the decline of -100% The ebitda of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 14.33 crore as compare to the Dec '25 ebitda of ₹ 17.16 crore. This represent the decline of -16.49% The ebitda of Vasundhara Rasayans Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 1.18 crore. This represent the decline of -100% The net profit of Jagsonpal Pharmaceuticals Ltd changed from ₹ 5.33 crore to ₹ 8.76 crore over 8 quarters. This represents a CAGR of 28.20% The net profit of Vasundhara Rasayans Ltd changed from ₹ 0.86 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Jagsonpal Pharmaceuticals Ltd changed from 15.36 % on March 2021 to 29.99 % on March 2025 . This represents a CAGR of 14.32% over 5 yearsThe Dividend Payout of Vasundhara Rasayans Ltd changed from 16.22 % on March 2021 to 14.96 % on March 2025 . This represents a CAGR of -1.60% over 5 years .

About Jagsonpal Pharmaceuticals Ltd

Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
In 1994, the company has also promoted Aresco Financial Services, a new financial company.

About Vasundhara Rasayans Ltd

Vasundhara Rasayans Limited was incorporated in March, 1987.
The Company is the leading manufacturer and exporter of Antacids therapeutic category of Active Pharmaceutical Ingredients with annual capacity of about 1500 MT of powder or its equivalent products.
It started its operation in year 1990 with an Antacid API facility offering product in paste, powder and micronised grade of powder. The plant is located on National Highway between Mumbai and Goa in an Industrial Zone called Mahad which is about 170 KMS from Mumbai and about 125 KMS from the NSICT /JNPT Ports Mumbai.
In addition to the API manufacturing Vasundhara is also having an API intermediate plant to handle organic products with its state of the art specialised Friedel Craft reaction facility. The manufacturing area is maintained as per GMP standards.

FAQs for the comparison of Jagsonpal Pharmaceuticals Ltd and Vasundhara Rasayans Ltd

Which company has a larger market capitalization, Jagsonpal Pharmaceuticals Ltd or Vasundhara Rasayans Ltd?

Market cap of Jagsonpal Pharmaceuticals Ltd is 1,388 Cr while Market cap of Vasundhara Rasayans Ltd is 41 Cr

What are the key factors driving the stock performance of Jagsonpal Pharmaceuticals Ltd and Vasundhara Rasayans Ltd?

The stock performance of Jagsonpal Pharmaceuticals Ltd and Vasundhara Rasayans Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jagsonpal Pharmaceuticals Ltd and Vasundhara Rasayans Ltd?

As of May 5, 2026, the Jagsonpal Pharmaceuticals Ltd stock price is INR ₹206.8. On the other hand, Vasundhara Rasayans Ltd stock price is INR ₹132.0.

How do dividend payouts of Jagsonpal Pharmaceuticals Ltd and Vasundhara Rasayans Ltd compare?

To compare the dividend payouts of Jagsonpal Pharmaceuticals Ltd and Vasundhara Rasayans Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.